Citadel Advisors’s IQ Candriam US Mid Cap Equity ETF IQSM Stock Holding History

Citadel Advisors’s Portfolio IQSM Stock Details IQSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,716	Closed	-$725K	–	13766
2025 Q1	$725K	Buy	23,716 +3,310	+16%	+$107K	﹤0.01%	7670
2024 Q4	$662K	Buy	+20,406	New	+$685K	﹤0.01%	7936
2024 Q2	–	Sell	-16,364	Closed	-$529K	–	14835
2024 Q1	$529K	Buy	+16,364	New	+$500K	﹤0.01%	8270
2023 Q4	–	Sell	-18,275	Closed	-$488K	–	14765
2023 Q3	$488K	Buy	18,275 +4,133	+29%	+$117K	﹤0.01%	8107
2023 Q2	$401K	Buy	+14,142	New	+$380K	﹤0.01%	8409

Other funds holding IQSM

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's IQSM Position: Q2 2025 in Review

Citadel Advisors sold out of IQ Candriam US Mid Cap Equity ETF (IQSM) in Q2 2025, closing a stake of 23,716 shares — an estimated $725K sold.

Citadel Advisors first reported a position in IQSM in Q2 2023 and held it in 5 quarters. The position peaked at $725K in Q1 2025. 3 funds tracked by Wall St. Rank hold IQSM as of Q2 2025.

Citadel Advisors reported no remaining IQ Candriam US Mid Cap Equity ETF position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 23,716 IQ Candriam US Mid Cap Equity ETF shares in Q2 2025, an estimated $725K.
Citadel Advisors first reported a position in IQ Candriam US Mid Cap Equity ETF in Q2 2023 and held it in 5 quarters.
Citadel Advisors's IQ Candriam US Mid Cap Equity ETF position peaked at $725K in Q1 2025.
3 funds tracked by Wall St. Rank held IQ Candriam US Mid Cap Equity ETF as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.